Company-level financial information

CVS HEALTH Corp

Selected annual earnings and cash-flow facts from SEC filings. Each row identifies its exact reporting period and original filing.

Annual net income

202020212022202320242025

Reported annual periods; USD. Negative values extend below the baseline.

Selected annual US-GAAP cash-flow and earnings facts · USD
Reporting periodMeasureUSD millionsFiling
Dec 31, 2025From Jan 1, 2025Operating cash flow10,639.0SEC filingFeb 10, 2026
Dec 31, 2025From Jan 1, 2025Net income1,768.0SEC filingFeb 10, 2026
Dec 31, 2025From Jan 1, 2025Total cash dividends3,397.0SEC filingFeb 10, 2026
Dec 31, 2025From Jan 1, 2025Capital expenditures (PP&E)2,832.0SEC filingFeb 10, 2026
Dec 31, 2024From Jan 1, 2024Operating cash flow9,107.0SEC filingFeb 10, 2026
Dec 31, 2024From Jan 1, 2024Net income4,614.0SEC filingFeb 10, 2026
Dec 31, 2024From Jan 1, 2024Total cash dividends3,373.0SEC filingFeb 10, 2026
Dec 31, 2024From Jan 1, 2024Capital expenditures (PP&E)2,781.0SEC filingFeb 10, 2026
Dec 31, 2023From Jan 1, 2023Operating cash flow13,426.0SEC filingFeb 10, 2026
Dec 31, 2023From Jan 1, 2023Net income8,344.0SEC filingFeb 10, 2026
Dec 31, 2023From Jan 1, 2023Total cash dividends3,132.0SEC filingFeb 10, 2026
Dec 31, 2023From Jan 1, 2023Capital expenditures (PP&E)3,031.0SEC filingFeb 10, 2026
Dec 31, 2022From Jan 1, 2022Operating cash flow16,177.0SEC filingFeb 12, 2025
Dec 31, 2022From Jan 1, 2022Net income4,311.0SEC filingFeb 12, 2025
Dec 31, 2022From Jan 1, 2022Total cash dividends2,907.0SEC filingFeb 12, 2025
Dec 31, 2022From Jan 1, 2022Capital expenditures (PP&E)2,727.0SEC filingFeb 12, 2025
Dec 31, 2021From Jan 1, 2021Operating cash flow18,265.0SEC filingFeb 7, 2024
Dec 31, 2021From Jan 1, 2021Net income8,001.0SEC filingFeb 7, 2024
Dec 31, 2021From Jan 1, 2021Total cash dividends2,625.0SEC filingFeb 7, 2024
Dec 31, 2021From Jan 1, 2021Capital expenditures (PP&E)2,520.0SEC filingFeb 7, 2024
Dec 31, 2020From Jan 1, 2020Operating cash flow15,865.0SEC filingFeb 8, 2023
Dec 31, 2020From Jan 1, 2020Net income7,179.0SEC filingFeb 8, 2023
Dec 31, 2020From Jan 1, 2020Total cash dividends2,624.0SEC filingFeb 8, 2023
Dec 31, 2020From Jan 1, 2020Capital expenditures (PP&E)2,437.0SEC filingFeb 8, 2023
Dec 31, 2019From Jan 1, 2019Operating cash flow12,848.0SEC filingFeb 9, 2022
Dec 31, 2019From Jan 1, 2019Net income6,634.0SEC filingFeb 9, 2022
Dec 31, 2019From Jan 1, 2019Total cash dividends2,603.0SEC filingFeb 9, 2022
Dec 31, 2019From Jan 1, 2019Capital expenditures (PP&E)2,457.0SEC filingFeb 9, 2022

Latest filed value per tag and exact annual period, within the last seven years. Common-stock and total cash dividends are separate measures; do not add them together. These selected facts are not a complete financial statement.